scholarly journals Successful Treatment of Persistent COVID 19 Infection in a Patient with Hypogammaglobulinemia with REGN-COV2: A Brief-Report

2021 ◽  
Author(s):  
Pankaj Luitel ◽  
Dana Vais ◽  
Adi Gidron
Keyword(s):  
Immune Response ◽  
Male Patient ◽  
Successful Treatment ◽  
Viral Antibodies ◽  
Compromised Patients

Abstract A 55-year-old-male patient with hypogammaglobulinemia due to previous rituximab treatment developed persistent COVID-19 pneumonia. Treatment with REGN-COV2 resulted in the clearance of the infection. Targeted anti-viral antibodies may be an important weapon in the management of immune-compromised patients infected by SARS-COV2 who fail to mount an immune response.

Effectiveness of an educational leaflet on the prevention of external genital warts recurrences

2005 ◽  
Vol 16 (12) ◽  
pp. 784-788 ◽  
Author(s):  
Juan José Vilata ◽  
Xavier Badia ◽  
Keyword(s):  
Immune Response ◽  
Confidence Intervals ◽  
Recurrence Rate ◽  
Successful Treatment ◽  
Genital Warts ◽  
Condyloma Acuminatum ◽  
Not Given ◽  
Global Rate ◽  
External Genital Warts

The study aims to assess the effectiveness of an educational leaflet in the prevention of external genital warts recurrences after achieving clearance with topical immune response modifiers treatment. A six-month follow-up, prospective, open, multi-centre randomized by centres study was conducted, which included a total of 216 patients. A total of 103 (47.7%) patients were given an educational leaflet. In all, 201 subjects (93.1%) came to the second follow-up visit, of which 62.7% achieved condyloma acuminatum (CA) clearance. During follow-up, 15% (confidence intervals [CI] 95%, 7.1–26.6%) of the patients who were given the educational leaflet, and 33.3% (CI 95%, 20.4–48.4%) of those who were not given the educational leaflet showed CA recurrences; the global rate of CA recurrence at the end of the six-month follow-up was 23.1% (CI 95%, 15.6–32.2%). The educational leaflet has therefore proved to be effective at reducing the recurrence rate after successful treatment with immune response modifiers.

scholarly journals Tuberculosis verrucosa cutis

2017 ◽  
Vol 2 (4) ◽  
Author(s):  
Krishnabharath S
Keyword(s):  
Immune Response ◽  
Male Patient ◽  
Clinical Examination ◽  
Histopathological Examination ◽  
Extrapulmonary Tuberculosis ◽  
Common Disease ◽  
Routine Treatment ◽  
Cutaneous Tuberculosis ◽  
Direct Inoculation

<p>We report a case of 23-year-old male patient with tuberculosis verrucous cutis on the foot for a duration of six months without responding to routine treatment. Tuberculosis is a common disease worldwide. Extrapulmonary tuberculosis contributes to 10% of cases. Cutaneous tuberculosis occupies a small spectrum of extrapulmonary tuberculosis. Tuberculosis verrucosa cutis is an exogenous infection occurring in a previously sensitized patient by direct inoculation of the organism. It occurs in sensitized patients with a moderate to high immune response. The diagnosis in our patient was confirmed by history, clinical examination, histopathological examination and the patient’s response to anti-tuberculous therapy.</p>

scholarly journals Non-surgical endodontic treatment of maxillary first molar with large size and curved canal: a case report

2018 ◽  
Vol 6 (1) ◽  
pp. 17
Author(s):  
Adnan Habib ◽  
Mazen Doumani ◽  
Muteb Almutairi
Keyword(s):  
Case Report ◽  
Male Patient ◽  
Successful Treatment ◽  
Root Canal ◽  
Rare Case ◽  
Radiographic Examination ◽  
Dental Tissues ◽  
Large Size ◽  
Working Length ◽  
Rare Case Report

The teeth are subjected to considerable variation for the number, size, form and structure of dental tissues. In this rare case report, a 30-year-old male patient was referred for root canal treatment of his right maxillary first molar because of deep caries in this tooth. During radiographic examination for determining the working length of this tooth, the peri-apical radiographs revealed the unfamiliar size of the maxillary first molar, in addition to severe curvature in mesiobuccal root. To achieve a successful treatment instrumentation of the canals completed with a crown-down technique, and obturation was done with lateral condensation technique.

scholarly journals Bilateral Proximal Tibiofibular Synostosis Caused by Osteochondroma in a 21-Year-Old Highly Active Male—First in Literature

Medicina ◽  
2021 ◽  
Vol 57 (10) ◽  
pp. 1126
Author(s):  
Lorenz Pisecky ◽  
Gerhard Großbötzl ◽  
Stella Stevoska ◽  
Christian Stadler ◽  
Maximilian Ziernhöld ◽  
...  
Keyword(s):  
Case Report ◽  
Knee Pain ◽  
Male Patient ◽  
Successful Treatment ◽  
Preoperative Diagnosis ◽  
Open Resection ◽  
Highly Active ◽  
Bilateral Case ◽  
Soccer Training ◽  
Proximal Tibiofibular Synostosis

Background and Objectives: Up until now, only one case of unilateral proximal tibiofibular synostosis caused by osteochondroma has been reported. This report is the first well-documented bilateral case of proximal tibiofibular synostosis caused by an osteochondroma. Case Report: A 21-year-old, highly active male patient with bilateral proximal tibiofibular synostosis caused by an osteochondroma suffering from persistent knee pain is presented. As conservative methods had failed, the patient was treated by bilateral open resection of the connecting bone. Histopathological findings confirmed the preoperative diagnosis. The patient returned to sports three weeks after surgery and continued soccer training six weeks after surgery. Discussion: The case report presents the successful treatment of a bilateral proximal tibiofibular synostosis caused by an osteochondroma by bilateral open resection of the connecting bone.

scholarly journals A Case Report of Successful Treatment of Mammary Myofibromyoblastoma in a Male Patient

2019 ◽  
Vol 9 (2-3) ◽  
pp. 26-28
Author(s):  
Omer Abdalla ◽  
Abhishek Chitnis ◽  
Banan Omer ◽  
Mohammed Elhadi ◽  
Muhammad Osman Karim ◽  
...  
Keyword(s):  
Case Report ◽  
Male Patient ◽  
Successful Treatment

scholarly journals A 33-Year-Old Man with Gynaecomastia and Galactorrhea as the First Symptoms of Graves Hyperthyroidism

2016 ◽  
Vol 2016 ◽  
pp. 1-3
Author(s):  
Somdul Khoohaphatthanakul ◽  
Apiradee Sriwijitkamol
Keyword(s):  
Physical Examination ◽  
Male Patient ◽  
Successful Treatment ◽  
Hormone Level ◽  
Thyroid Stimulating Hormone ◽  
Graves Disease ◽  
The Third ◽  
Rare Manifestation ◽  
Laboratory Investigations ◽  
Male Patients

Graves’ hyperthyroidism has a various number of well-recognized manifestations. Galactorrhea is a rare manifestation in this disease. We describe a 33-year-old man who presented with the symptoms of hyperthyroidism, gynaecomastia, and galactorrhea for 2 months. Physical examination revealed goitre, gynaecomastia, and galactorrhea, bilaterally. Laboratory investigations demonstrated high free thyroxine with suppressed thyroid-stimulating hormone level together with elevated anti-TSH receptor; therefore, the diagnosis of Graves’ disease was confirmed. Other investigations to elucidate the etiology of galactorrhea were normal, so the galactorrhea was hypothesized to be caused by Graves’ disease. The gynaecomastia and galactorrhea resolved with the successful treatment of hyperthyroidism. Although the galactorrhea is extremely rare in thyrotoxicosis male patients, to the best of our knowledge, this is the third case which reported gynaecomastia and galactorrhea in male patient who presented with thyrotoxicosis.

Successful treatment of breast cancer‐related breast lymphedema by lymphovenous anastomosis in a male patient

Microsurgery ◽  
2019 ◽  
Vol 39 (4) ◽  
pp. 360-363 ◽  
Author(s):  
Guido Giacalone ◽  
Takumi Yamamoto ◽  
Florence Belva ◽  
Rudiger Wets ◽  
Akitatsu Hayashi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Male Patient ◽  
Successful Treatment ◽  
Lymphovenous Anastomosis

scholarly journals Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy

2018 ◽  
Vol 11 (1) ◽  
pp. 29-32 ◽  
Author(s):  
Taku Fujimura ◽  
Kayo Tanita ◽  
Yota Sato ◽  
Yumi Kambayashi ◽  
Sadanori Furudate ◽  
...  
Keyword(s):  
Immune Response ◽  
T Cell ◽  
Mycosis Fungoides ◽  
Successful Treatment ◽  
Cell Lymphoma ◽  
T Cell Lymphoma ◽  
Antitumor Immune Response ◽  
Cutaneous T Cell Lymphoma ◽  
Lymphoma Cells ◽  
Dependent Cell

Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in Sézary syndrome (47.1%), reagents that enhance the antitumor immune response induced by mogamulizumab are needed to further optimize its use for the treatment of erythrodermic mycosis fungoides. In this report, we present a case of erythrodermic mycosis fungoides successfully treated with mogamulizumab followed by etoposide monotherapy.

Sign in / Sign up

Export Citation Format

Share Document